US 9585863
Treatment of cataplexy
granted A61KA61K31/27A61K31/325
Quick answer
US patent 9585863 (Treatment of cataplexy) held by Jazz Pharmaceuticals International III Limited expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jazz Pharmaceuticals International III Limited
- Grant date
- Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/27, A61K31/325, A61K45/06, A61K9/0053